COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1682.2 | 8 | 0074-0126 | 312.43 | 126.66 | 288 | 67.94 | 0.784 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1717.7 | 8 | 0075-0127 | 651.45 | 127.21 | 274 | 62.53 | 0.881 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 509.1 | 8 | 0076-0124 | 693.52 | 124.41 | 100 | 38.63 | 0.842 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 520.8 | 8 | 0077-0134 | 544.06 | 133.88 | 328 | 69.60 | 0.851 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2947.2 | 8 | 0078-0131 | 834.06 | 131.69 | 238 | 57.36 | 0.909 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2309.0 | 8 | 0079-0134 | 916.21 | 133.84 | 333 | 69.01 | 0.879 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 4375.7 | 8 | 0080-0139 | 433.99 | 140.31 | 312 | 67.60 | 0.858 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2425.6 | 8 | 0081-0141 | 742.85 | 142.35 | 182 | 53.36 | 0.803 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1685.8 | 8 | 0082-0142 | 371.39 | 142.67 | 287 | 66.18 | 0.823 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 809.9 | 8 | 0083-0142 | 691.60 | 143.08 | 137 | 49.70 | 0.697 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2137.4 | 8 | 0084-0147 | 102.87 | 147.30 | 221 | 58.28 | 0.818 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2064.2 | 8 | 0085-0146 | 870.70 | 146.58 | 274 | 63.36 | 0.858 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 367.0 | 8 | 0086-0145 | 813.59 | 145.20 | 244 | 62.53 | 0.784 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2699.9 | 8 | 0087-0147 | 260.69 | 146.47 | 195 | 52.53 | 0.888 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1144.1 | 8 | 0088-0151 | 610.95 | 151.63 | 257 | 69.60 | 0.667 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2292.4 | 8 | 0089-0151 | 508.14 | 151.35 | 210 | 54.77 | 0.880 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 5051.9 | 8 | 0090-0152 | 201.67 | 152.39 | 324 | 67.01 | 0.907 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1801.5 | 8 | 0091-0153 | 752.90 | 153.76 | 193 | 51.70 | 0.907 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1449.2 | 8 | 0092-0154 | 646.52 | 153.18 | 233 | 58.53 | 0.855 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 419.3 | 8 | 0093-0163 | 790.71 | 165.01 | 286 | 78.43 | 0.584 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1987.8 | 8 | 0094-0160 | 115.51 | 160.99 | 260 | 59.36 | 0.927 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1432.4 | 8 | 0095-0163 | 155.98 | 162.80 | 258 | 62.43 | 0.832 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1599.5 | 8 | 0096-0167 | 638.49 | 167.91 | 284 | 66.67 | 0.803 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 743.7 | 8 | 0097-0169 | 319.81 | 169.39 | 287 | 62.18 | 0.933 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 391.2 | 8 | 0098-0170 | 387.76 | 170.51 | 216 | 54.53 | 0.913 |